oxidative dna damage in female patients with diabetes mellitus type 2.
Clicks: 303
ID: 235692
2015
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
303 views
44 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #68 of 264 articles by views in chemical record (new york, ny)
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 264 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Diabetes mellitus type 2 is very often associated with increased levels of reactive oxygen species. Previous studies also showed higher DNA damage in patients with diabetes mellitus type 2 compared to healthy controls (Tatsch et al., 2012; Blasiak et al., 2004). However, blood glucose concentration and level of glycated hemoglobin (HbA1c) can vary widely between diabetic patients and depends on country specific threshold levels.
Therefore our aim was to analyze DNA damage in patients with lower glycated hemoglobin (HbA1c<7.5%; n=74) vs. patients with higher glycated hemoglobin (HbA1c>7.5%; n=72). In total 146 patients of the local diabetes outpatient clinic in Vienna were enrolled (age: 67.5±9,9years; BMI: 35.0±7.6kg/m²; diabetes duration: 14.4±8.0years).The Comet assay was performed in PBMCs (strand breaks, resistance to H2O2, FPG-sensitive sites) and whole blood (strand breaks, FPG-sensitive sites).
No differences in DNA damage were found between the two groups of low vs. high HbA1c. In addition, neither diabetes duration nor medication (Insulin vs. oral antidiabetics) had an influence on DNA damage.
Therefore we can conclude that female patients with diabetes mellitus type 2 in Austria are under optimal treatment to control blood sugar and other metabolic parameter, that no differences in DNA damage could be observed.
| Reference Key |
guggenberger2015frontiersoxidative
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Bianca Guggenberger;Annemarie Grindel |
| Journal | chemical record (new york, ny) |
| Year | 2015 |
| DOI |
10.3389/conf.fgene.2015.01.00030
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.